[1] SAMARGHANDIAN S, AZIMI-NEZHAD M, FARKHONDEH T, et al. Anti-oxidative effects of curcumin on immobilization-induced oxidative stress in rat brain, liver and kidney[J].Biomed Pharmacother, 2017, 87:223
[2] WANF QR, YE CQ, SUN SK, et al. Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects[J].Int Immunopharmacol, 2019, 72:292
[3] TOMEH MA, HADIANAMREI R, ZHAO XB. A Review of curcumin and its derivatives as anticancer agents[J].Int J Mol Sci, 2019, 20(5):1033
[4] ALQAHTANI AM, CHIDAMBARAM K, PINO-FIGUEROA A, et al. Curcumin-celecoxib:a synergistic and rationale combination chemotherapy for breast cancer[J].Eur Rev Med Pharmacol Sci, 2021, 4(25):1916
[5] CAO WX, CHEN X, CHIN YX, et al. Identification of curcumin as a potential α-glucosidase and dipeptidyl-peptidase 4 inhibitor: molecular docking study, in vitro and in vivo biological evaluation[J].J Food Biochem, 2022, 46(3):e13686
[6] SINGH L, SHARMA S, XU SW, et al. Curcumin as a natural remedy for atherosclerosis: a pharmacological review[J].Molecules, 2021, 26(13):4036
[7] TIAN MY, ZHOU FL, TENG ZP, et al. Curcumin ameliorates lipid metabolic disorder and cognitive dysfunction via the ABCA1 transmembrane transport system in APP/PS1 double transgenic mice[J].J Integr Neurosci, 2021, 20(4):895
[8] LIU WD, ZHAI YJ, HENG XY, et al. Oral bioavailability of curcumin:problems and advancements[J].J Drug Target, 2016, 24(8):694
[9] WANG JJ, YU XJ, ZHANG L, et al. The pharmacokinetics and tissue distribution of curcumin and its metabolites in mice[J].Biomed Chromatogr, 2018, 32:e4267
[10] ZENG Z, SHEN ZL, ZHAI S, et al. Transport of curcumin derivatives in Caco-2 cell monolayers[J].Eur J Pharm Biopharm, 2017, 117:123
[11] TABANELLI R, BROGI S, CALDERONE V. Improving curcumin bioavailability:current strategies and future perspectives[J].Pharmaceutics, 2021, 13(10):1715
[12] BHUKET PRN, EL-MAGBOUB A, HAWORTH IS, et al. Enhancement of curcumin bioavailability via the prodrug approach:challenges and prospects[J].Eur J Drug Metab Pharmacokinet, 2017, 42(3):341
[13] HAN HK. The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs[J].Expert Opin Drug Metab Toxicol,2011,7(6):721
[14] 任金妹,李曼,谢宁,等.提高姜黄素口服生物利用度方法的研究进展[J].中国药房,2018, 29(23):3303
REN JM, LI M, XIE N, et al. Research progress in improving oral bioavailability of curcumin[J].China Pharm, 2018, 29(23):3303
[15] ZENG XH, CAI D, ZENG QH, et al. Selective reduction in the expression of UGTs and SULTs, a novel mechanism by which piperine enhances the bioavailability of curcumin in rat[J].Biopharm Drug Dispos, 2017, 38(1):3
[16] LI XP, UEHARA S, SAWANGRAT K, et al. Improvement of intestinal absorption of curcumin by cyclodextrins and the mechanisms underlying absorption enhancement[J].Int J Pharm, 2018, 535(1):340
[17] HE XY, LI GW, CHEN YY, et al. Pharmacokinetics and pharmacodynamics of the combination of rhein and curcumin in the treatment of chronic kidney disease in rats[J].Front Pharmacol, 2020, 11:573118
[18] KONO Y, KAWAHARA I, SHINOZAKI K, et al. Characterization of P-glycoprotein inhibitors for evaluating the effect of P-glycoprotein on the intestinal absorption of drugs[J].Pharmaceutics, 2021, 13(3):388
[19] LOPES-RODRIGUES V, SOUSA E, VASCONCELOS MH. Curcumin as a modulator of p-glycoprotein in cancer:challenges and perspectives[J].Pharmaceuticals, 2016, 9(4):71
[20] ZHANG QY, WANG JZ, HE HB, et al. Trametenolic acid B reverses multidrug resistance in breast cancer cells through regulating the expression level of P-glycoprotein[J].Phytother Res, 2014, 28(7):1037
[21] ZHOU W, CHENG C, MA L, et al. The Formation of chitosan-coated rhamnolipid liposomes containing curcumin: stability and in vitro digestion[J].Molecules, 2021, 26(3):560
[22] ASWAR M, BHALEKAR M, TRIMUKHE A, et al. Self-microemulsifying drug delivery system(SMEDDS) of curcumin attenuates depression in olfactory bulbectomized rats[J].Heliyon, 2020, 6(8):e4482
[23] HU QB, LUO YC. Chitosan-based nanocarriers for encapsulation and delivery of curcumin: a review[J].Int J Biol Macromol, 2021, 179:125
[24] GRILC NK, SOVA M, KRISTL J. Drug delivery strategies for curcumin and other natural Nrf2 modulators of oxidative stress-related diseases[J].Pharmaceutics, 2021, 13(12):2137
[25] JAISAMUT P, WIWATTANAWONGSA K, WIWATTANAPATAPEE R. A novel self-microemulsifying system for the simultaneous delivery and enhanced oral absorption of curcumin and resveratrol[J].Plant Med, 2017, 83(5):461
[26] SAHU BP, HAZARIKA H, R BHARADWAJ, et al. Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity[J].Expert Opin Drug Deliv, 2016, 13(8):1065
[27] 王堃. 肠道CYP3A和P-gp:口服药物的吸收屏障[J].中国药理学通报, 2003, 19(11):1216
WANG K. The intestinal cytochrome P450 3A and P-glycoprotein:barriers to drug absorption[J].Chin Pharmacol Bull, 2003, 19(11):1216
[28] SUN XL, LI JX, GUO CR, et al. Pharmacokinetic effects of curcumin on docetaxel mediated by OATP1B1, OATP1B3 and CYP450s[J].Drug Metab Pharmacokinet, 2016, 31(4):269
[29] BAHRAMSOLTANI R, RAHIMI R, FARZAEI MH. Pharmacokinetic interactions of curcuminoids with conventional drugs:A review[J].J Ethnopharmacol, 2017, 209:1
[30] GIORDANO A, TOMMONARO G. Curcumin and cancer[J].Nutrients, 2019, 11(10):2376
[31] LIU Q, LOO WTY, SZE SCW, et al. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappa B, cyclin D and MMP-1 transcription[J].Phytomedicine(Stuttgart), 2009, 16(10):916
[32] JIN H, QIAO F, WANG Y, et al. Curcumin inhibits cell proliferation and induces apoptosis of human non-small cell lung cancer cells through the upregulation of miR-192-5p and suppression of PI3K/Akt signaling pathway[J].Oncol Rep, 2015, 34(5):2782
[33] DAS L, VINAYAK M. Curcumin attenuates carcinogenesis by down regulating proinflammatory cytokine interleukin-1(IL-1alpha and IL-1beta) via modulation of AP-1 and NF-IL6 in lymphoma bearing mice[J].Int Immunopharmacol, 2014, 20(1):141
[34] SHEHZAD A, WAHID F, LEE YS. Curcumin in cancer chemoprevention:molecular targets, pharmacokinetics, bioavailability, and clinical trials[J].Arch Pharm(Weinheim), 2010, 343(9):489
[35] XUE X, YU JL, SUN DQ, et al. Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways[J].Asian Pac J Cancer Prev,2014,15(9):3987
[36] ZHANG X, ZHANG CL, REN ZH, et al. Curcumin affects gastric cancer cell migration, invasion and cytoskeletal remodeling through gli1-beta-catenin[J].Cancer Manag Res, 2020, 12:3795
[37] SHI FF, FU YH, WANG JZ, et al. Trametenolic acid B triggers HSP90AA4P and autophagy in HepG2/2.2.15 cells by proteomic analysis[J].ACS Omega, 2020, 5(22):13042
[38] ZHANG QY, HUANG NY, WANG JZ, et al. The H +/K +-ATPase inhibitory activities of trametenolic acid B from Trametes lactinea(Berk.) Pat, and its effects on gastric cancer cells[J].Fitoterapia, 2013, 89:210
[39] 王爱玲,叶汪阳,汪鋆植. 3-氢化松苓酸B对宫颈癌U14的影响[J].三峡大学学报,2019,41(2):108
WANG AL, YE WY, WANG JZ, et al. Effect of Trametenolic Acid B on cervical cancer U14 cells[J].J China Three Gorges Univ(Nat Sci), 2019, 41(2):108
[40] 袁园,汪鋆植,邓李蓉,等. 栓菌酸对耐索拉非尼肝癌细胞HepG2/Sora的影响及机制[J].中药药理与临床,2022,38(3):76
YUAN Y, WANG JZ, DENG LR, et al. Effect of trametenolic acid B on sorafenib resistance in hepatoma cell line HepG2/Sora and its mechanism[J].Pharmacol Clin Chin Mater Med, 2022,38(3):76
[41] 王妍妍. 茯苓对大鼠细胞色素P450酶活性及mRNA表达的影响[D].合肥:安徽中医药大学,2017
WANG YY. Effect of Poria Cocos on Cytochrome P450 Enzyme Activity and Mrna Expression in Rats[D].Hefei:Anhui University of Chinese Medicine,2017
